Amlodipine-induced reversible gum hypertrophy

Gingival hypertrophy is a common manifestation of any pathology affecting gingival and periodontal regions. It commonly follows inflammatory disorders, Vitamin C deficiency, leukemia and due to drugs such as anticonvulsants, immunosuppressants, and calcium channel blockers. Amlodipine is a third gen...

Full description

Saved in:
Bibliographic Details
Published inArchives of pharmacy practice Vol. 7; no. 3; pp. 103 - 105
Main Authors Manish, Gutch, Shobhit, Shakya, Sukriti, Kumar, Bhattacharjee, Annesh, Singh, Rao
Format Journal Article
LanguageEnglish
Published Wolters Kluwer - Medknow Publications 01.07.2016
Archives of Global Professionals
Subjects
Amlodipine
calcium channel blockers
gingival hypertrophy
calcium channel blockers
Amlodipine
gingival hypertrophy
Online AccessGet full text

Cover

More Information
Summary:Gingival hypertrophy is a common manifestation of any pathology affecting gingival and periodontal regions. It commonly follows inflammatory disorders, Vitamin C deficiency, leukemia and due to drugs such as anticonvulsants, immunosuppressants, and calcium channel blockers. Amlodipine is a third generation dihydropyridine derived calcium channel blocker commonly used to treat hypertension. Here, we describe the case of a 45-year-old hypertensive woman who was on amlodipine for 1 year and subsequently developed one of its rarest adverse effects, i.e., gingival hypertrophy.
ISSN:2045-080X
2045-080X
DOI:10.4103/2045-080X.186175